PODD STOCK ANALYSIS

Insulet Corporation — price, returns and risk statistics

PODDInsulet Corporation

🇺🇸 USA · US · Healthcare · Medical Devices

Value itDuel

Price summary

Last Close

164.48 $

Jul 2, 26

Market Cap

11.5 B $

Q1 2026 (TTM)

52-Week Range

138.97 $352.82 $

Return and risk cards

Total Return

%-45.5

Trailing 1-year performance

Volatility

%39.4

Price fluctuation measure

Sharpe Ratio

-2.36

Risk/Return ratio

Sortino Ratio

-2.16

Downside risk/return

Distance to Peak

%-53.4

Difference from 52-week peak

Maximum Drawdown

-%60.6

Deepest 1-year decline

Seasonality

Seasonality Chart

Year 2023
Year 2024
Year 2025
Current Period 2026
3/3 positive months

Periodic Returns

1M

+15.5%

3M

-19.5%

6M

-42.1%

YTD

-42.1%

1Y

-45.5%

3Y

-42.0%

Returns are computed from split-adjusted closes; dividends are not included.

YTD Return — Stock vs Asset Classes

Year-to-date
PODD-42.1%Gold-3.8%Silver-11.3%S&P 500+9.3%

Stock and gold/silver returns are in USD (metals converted into the stock's currency). The S&P 500 index is measured in its own currency.

Monthly positivity

Monthly Avg Positive/Negative Close

Positive Count
Negative Count
Average Positive %
Average Negative %

Frequently Asked Questions

What is the current Insulet Corporation (PODD) stock price?

PODD last closed at 164.48 $ (Jul 2, 26). Price data is refreshed after every trading day.

What is the P/E ratio of PODD?

Insulet Corporation trades at a trailing-twelve-month P/E of 38.13. See the comparison tables on the Peers tab for the industry context.

What is the market capitalization of Insulet Corporation?

Insulet Corporation (PODD) has a market capitalization of approximately 11.5 B $ as of the latest reported period.

Who are the main competitors of PODD?

Key peers of Insulet Corporation include Cochlear Ltd, Koninklijke Philips NV, Siemens Healthineers AG, 4DMEDICAL Ltd. A detailed metric comparison is available on the Peers tab.

Go deeper on PODD

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.